Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Tropic Biosciences has raised $105.0M in total funding. The most recent round was Series C. The last funding was announced in March 2026.
Tropic Biosciences's investors include Temasek Holdings, IQ Capital, Polaris Partners, Forbion Capital Partners, Future Planet Capital.
Tropic Biosciences is headquartered in London, United Kingdom.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Tropic Biosciences is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tropic Biosciences — Funding & Investors." VCBacked, March 12, 2026, https://www.vcbacked.co/company/tropic-biosciences. Accessed July 19, 2026.
VCBacked. (2026). Tropic Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tropic-biosciences
{{cite web |title=Tropic Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tropic-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated